The BRAF inhibitor vemurafenib activates mitochondrial metabolism and inhibits hyperpolarized pyruvate-lactate exchange in BRAF mutant human melanoma cells

Por Delgado-Goni, Teresa, Falck Miniotis, Maria, Wantuch, Slawomir, Parkes, Harold G., Marais, Richard, Workman, Paul, Leach, Martin O., Beloueche-Babari, Mounia
Publicado no Mol Cancer Ther (2016)

Detecting human melanoma cell re-differentiation following BRAF or heat shock protein 90 inhibition using photoacoustic and magnetic resonance imaging

Por Shah, Anant, Delgado-Goni, Teresa, Casals Galobart, Teresa, Wantuch, Slawomir, Jamin, Yann, Leach, Martin O., Robinson, Simon P., Bamber, Jeffrey, Beloueche-Babari, Mounia
Publicado no Sci Rep (2017)

Improving the classification of brain tumors in mice with perturbation enhanced (PE)-MRSI

Por Simões, Rui V, Ortega-Martorell, Sandra, Delgado-Goñi, Teresa, le Fur, Yann, Pumarola, Marti, Candiota, Ana P, Cozzone, Patrick J, Juliá-Sapè, Margarida, Arús, Carles
Publicado em 2010

A new ex vivo method to evaluate the performance of candidate MRI contrast agents: a proof-of-concept study

Por Candiota, Ana Paula, Acosta, Milena, Simões, Rui Vasco, Delgado-Goñi, Teresa, Lope-Piedrafita, Silvia, Irure, Ainhoa, Marradi, Marco, Bomati-Miguel, Oscar, Miguel-Sancho, Nuria, Abasolo, Ibane, Schwartz, Simó, Santamaria, Jesús, Penadés, Soledad, Arús, Carles
Publicado em 2014